Compare

Brenntag/€BNR

1D1W1M3M6MYTD1Y5YMAX

About Brenntag

Brenntag SE is a global leader in chemical distribution, providing comprehensive solutions in the chemical sector to a diverse range of industries, including pharmaceuticals, personal care, and coatings. Founded in 1874 and headquartered in Essen, Germany, the company operates an extensive network delivering both industrial and specialty chemicals worldwide. Brenntag is listed on the Frankfurt Stock Exchange under the ticker symbol 'BNR', reflecting its significant role in the global market as a connector between chemical manufacturers and an array of industry consumers.
Ticker
€BNR
Sector
Industrials
Primary listing
XETRA
Employees
16,942
Headquarters
Essen, Germany
Website
www.brenntag.com

Brenntag Metrics

BasicAdvanced
€8.9B
24.48
€2.52
0.53
€1.90
3.08%

What the Analysts think about Brenntag

Analyst ratings (Buy, Hold, Sell) for Brenntag stock.
Analyst projections of the future price of Brenntag stock.

Bulls say / Bears say

Second-quarter operating EBITDA rose 41% to €463 million, and Brenntag lifted its 2026 guidance to €1.35–1.45 billion. This gives the company a stronger earnings base for the year, although the quarter also benefited from higher chemical prices. (Brenntag)
The cost programme delivered €41 million of savings in the second quarter, and Brenntag is targeting €200–250 million of savings by 2027. If delivered, these recurring efficiencies could support profitability beyond the current pricing upswing. (Brenntag)
Specialties is showing growth in more focused markets: second-quarter gross profit rose 8.8%, with organic EBITDA growth across its business units. The planned Woojin Trading acquisition would also broaden Brenntag’s reach in South Korea’s beauty and personal care market. (Brenntag, Brenntag)
A significant part of the recent earnings uplift came from conflict-driven chemical price increases and supply disruption. Deutsche Bank warned that Brenntag is particularly exposed if these temporary tailwinds reverse as conditions normalise. (Investing.com)
Underlying demand remains a concern: first-quarter sales and EBITDA fell, while second-quarter volumes were stable rather than growing. Continued weak customer demand could limit organic growth even if cost savings continue. (Brenntag, Brenntag)
Cash conversion was weak in the second quarter: free cash flow was just €4 million, against €154 million a year earlier, as higher prices tied up more working capital. A prolonged increase in working-capital needs could constrain cash available for investment or shareholder returns. (Brenntag)
Data summarised monthly by Lightyear AI. Last updated on 3 Nov 2026.

Brenntag Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Brenntag Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Brenntag

AllEURUSDGBP
Funds
Fund name
Fund size
€BNR weighting
iShares STOXX Europe 600 Chemicals€EXV7
€103M3.11%
iShares DivDAX€EXSB
€562M1.24%
iShares EURO STOXX Mid€DJMC
€595M0.89%
iShares EURO STOXX Mid Cap£DJMC
€595M0.89%
iShares STOXX Europe Mid 200€EXSD
€610M0.44%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.